Mulmit

Amneal Pharmaceuticals, Inc.Amneal Pharmaceuticals, Inc.

AMRX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-313,018,760,000394,096,00072,057,0000.22
2024-12-312,793,957,000249,326,000-116,886,000-0.38
2023-12-312,393,607,000204,374,000-83,993,000-0.48
2022-12-312,212,304,000-94,928,000-270,584,000-0.86
2021-12-312,093,669,000152,716,00013,163,0000.07

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-01BOYER ANDREW SExecutive Vice President80,000
2026-08-21BOYER ANDREW SExecutive Vice President152,426
2026-08-13Kiely John50,000
2026-08-13Kiely John10,000
2026-08-12Shah NikitaExecutive Vice President146,403
2026-08-12Daly Jason B.EVP, Chief Legal Officer210,000
2026-08-11Daly Jason B.EVP, Chief Legal Officer6,613
2026-08-11BUCHI J KEVIN168,573
2026-08-10Patel ChintuCo-CEO6,381,734
2026-08-10Patel Gautam283,632
2026-08-10Patel Chirag K.President & Co-CEO6,381,734
2026-08-10Patel Tushar Bhikhubhai12,763,469

8-K events

FiledItems
2026-08-10Entry into a material agreement · Completed acquisition or disposition of assets · Creation of a direct financial obligation · Unregistered sales of equity securities · Regulation FD disclosure · Financial statements and exhibits
2026-08-03Entry into a material agreement
2026-07-31Submission of matters to a vote
2026-07-30Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-05-07Submission of matters to a vote
2026-05-07Results of operations · Financial statements and exhibits
2026-04-22Entry into a material agreement · Results of operations · Unregistered sales of equity securities · Regulation FD disclosure · Financial statements and exhibits
2026-02-27Results of operations · Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.